CIVETS Medical Device Market Reports

Publisher Name :
Date:29-Jan-2014
No. of pages: 0

The CIVETS Medical Device Market Reports provide the latest available data, expert analysis and our independent 5-year forecasts for key CIVETS markets. Each country report covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.

Key uses of Medical Devices Reports

  • Forecast the pace and stability of each CIVETS country’s economic and industry growth
  • Identify and evaluate adverse political and economic trends in key markets, to facilitate risk mitigation strategies
  • Assess critical shortcomings of each CIVETS country’s business environment that pose hidden barriers and costs to corporate profitability
  • Contextualise individual CIVETS country risks against their CIVETS regional peers using BMI’s country-comparative risk ratings system
  • Target business opportunities in the key-growth industry sectors
  • Evaluate external threats to doing business in each CIVETS country, including currency volatility, the commodity price boom and protectionist policies

6 Key Markets Covered

Highly detailed analysis providing comprehensive regularly updated reports for leading markets in the region.

CIVETS Medical Device Market Reports

  • Colombia
  • Indonesia
  • Vietnam
  • Egypt
  • Turkey
  • South Africa

CIVETS Medical Device Market Reports

N/A

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • 2014 Deep Research Report on Global and China Laser Scanning Confocal Microscope Industry
    Published: 23-Jul-2014        Price: US $2200 Onwards        Pages: 187
    This is a professional and depth research report on Global and China Laser Scanning Confocal Microscope industry. The report firstly introduced Laser Scanning Confocal Microscope basic information included Laser Scanning Confocal Microscope definition classification application industry chain structure industry overview; Laser Scanning Confocal Microscope production and sales by manufacturers by technology by regions or countries, and also introduced global key manufacturers manufacturing bases ......
  • Czech Republic Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales data from the first quarter. Price declines throughout Europe and restructuring of the healthcare system will continue to impact demand within the Czech Republic. We also believe the new centre-left coalition government poses downside risk to our forecasts given its commitment to containing healthcare costs and improving access to medicines. Despite these concerns, our view is more optimistic over ......
  • Denmark Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 58
    BMI View: Like many other Western European countries, Denmark's expanding elderly population will ensure that demand for quality healthcare remains high and will be a key driving factor for its wellestablished, albeit relatively small, pharmaceutical market. The robust demand for healthcare services will see the Danish government continue to adapt strategies and cost-containment measures to manage increasing healthcare costs. Despite this, we believe the country's high per-capita drug expenditur......
  • France Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
    Published: 23-Jul-2014        Price: US $4350 Onwards        Pages: 615
    This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Report HighlightsBusiness and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • Iraq Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 83
    BMI View: Thanks to the government's expansionary fiscal policy, spending on education, health and public services will increase. The Iraqi government has reportedly pledged to invest USD12bn into healthcare expansions in 2014, and the Ministry of Health recently awarded 18 health project contracts worth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered the country in previous years, targeting control over drug policy and ensuring the supply of medicine......
  • Kuwait Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 123
    BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014, and the prospects for consumption remain bright. While price harmonisation across the GCC is likely to have a significant impact on margins in the sector, implementation remains slow. Concern over fake generic drugs presents opportunities for the segment in the country, and has spurred partnership agreements with local distributors in the region. Healthcare spending will remain strained as the ......
  • Malaysia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 145
    BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality and access to healthcare, as the government plans to expand and upgrade its hospital network. However, we have downgraded Malaysia's pharmaceutical sales forecast due to a slowdown in pharmaceutical trade in 2013. The country's slower economic growth in 2014, coupled with the fact that investment in the pharmaceuticals sector will take longer than expected to bring returns, are downside risks to our ......
  • ConMed: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
    Published: 23-Jul-2014        Price: US $1850 Onwards        Pages: 25
    A strategic assessment of ConMed, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.......
  • Portugal Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare market to return to growth in 2015, while pharmaceuticals will not return to growth until 2019. This is because while Portugal exited its bailout programme in May 2014 without the need for a new financial package, government austerity measures are likely to curb pharmaceutical reimbursement. Portug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs